Showing 102 of 102on this page. Filters & sort apply to loaded results; URL updates for sharing.102 of 102 on this page
Earendil Labs - Protein Therapeutics Discovery with Next-Generation AI
Earendil Labs and Sanofi Forge ~$2.56B Deal to Advance Bispecific ...
Earendil Labs Partners with Sanofi on AI-Driven Bispecific Antibody ...
WuXi XDC Partners with Earendil Labs on WuXiTecan-2 Payload-Linker ...
AI Biotech Earendil Labs Raises $787M - DevX
Earendil Labs sella un acuerdo de 750 millones con WuXi XDC para ...
Earendil Labs Raises USD 787 Million to Scale AI-Driven Biologics ...
AI Biologics Drug Discovery: Earendil Labs $787M Funding | IntuitionLabs
Earendil Labs secures $787 million to scale AI-driven biologics ...
Earendil Labs secures USD787M in funding to accelerate AI-powered drug ...
Earendil Labs Raises $787M for AI Biologics, and Nebius Secures $4.34B ...
WuXi Biologics Signs Strategic Collaboration with Earendil Labs ...
China-rooted AI biotech Earendil Labs raises $787M ahead of possible IPO
Sanofi Licenses AI-Discovered Biologics from Earendil Labs | Contract ...
Earendil Labs raises $787m to scale AI-driven biologics discovery and ...
Earendil Labs Announces Worldwide Exclusive License Agreement with ...
Earendil Labs to Scale AI-Driven Biologics Platform with $787 Million ...
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven ...
Earendil Labs and Sanofi Forge Strategic Collaboration to Advance AI ...
Earendil Labs Raises Nearly $800 Million for AI-Assisted Development of ...
China's WuXi XDC partners with Earendil Labs for Payload-Linker ...
WuXi XDC Strikes $885 Million ADC Deal with Earendil Labs – 24/7 BIOPHARMA
Earendil Labs lands $787M to fund biologics development push
Earendil Labs expands collaboration with Sanofi | The Pharmaletter
Earendil Labs Partners With Genentech on Bispecific Cancer Antibodies ...
Earendil Labs Launches Phase 1 Study of Innovative Anti-TL1A Antibody ...
Sanofi and Earendil Labs forge $2.56bn autoimmune deal
Earendil Labs Raises $787 Million To Scale AI Driven Biologics ...
Sanofi y Earendil Labs amplían sus vínculos con un acuerdo ...
Sanofi and Earendil Labs Ink $1.8B Deal to Advance AI-Designed ...
Sanofi strikes USD2.56B AI deal with Earendil Labs for autoimmune ...
Earendil Labs | Company Profile | Pharmacompass.com
Earendil Labs - Drug pipelines, Patents, Clinical trials - Synapse
Earendil Labs Revenue & Market Share 2026 | Life Sciences & BioTech
Earendil Labs holds massive USD 787m financing for AI-driven biologics ...
Earendil Labs Announces $787 Million in Financing to Scale A
Earendil Labs Eyes Hong Kong IPO After $3.4B in AI Biotech Deals — The ...
Earendil raises $787m as lead TL1A antibody starts phase 2 | pharmaphorum
Earendil Labs, an AI-powered drugmaker, hauls in $787M | BioPharma Dive
Earendil Labs' $787 million raise signals shift towards a multipolar ...
Sanofi, Earendil Lab ink $2.5B deal for bispecific antibody
Earendil strikes $885 million ADC alliance with WuXi XDC ...
Earendil Labs, an AI-powered drugmaker, hauls in $787M
Sanofi licenses immune disease drugs from startup Earendil | BioPharma Dive
Beursgang Earendil Labs: AI als motor voor biotech. | IT INSIGHTS
Earendil raises $787 million to scale AI-led biologics push ...
Earendil Business Services - Earendil Business Services | LinkedIn
Earendil Labs, Growth $787M – 글로벌 VC 메가딜 브리핑
US AI drug startup Earendil said to consider Hong Kong IPO
台灣科技製造業資訊共享平台 | ivendor科技聯盟
刷新2026融资纪录丨7.87亿美元！华深智药海外主体再获巨资|海外额度榜|辉瑞公司|研发|临床|资本_手机新浪网
WuXi XDC Expands ADC Platform with AI Partner
China’s AI drug discovery startups cash in on billion-dollar deals ...
AI Biologics Discovery: 2026 Pharma Investment Trends | IntuitionLabs
7.87亿美元！华森制药海外AI平台获DST、高瓴、赛诺菲抢投 来源：市场资讯（来源：药研网）2026年3月20日，致力于推进新一代生物制剂的 ...
100 Top Companies in Delaware · July 2026 | F6S
18.45亿美元！赛诺菲引进华深智药两款双抗 - 知乎
南京天印山医院
Home - PharmaShots
Office Address
Weekly Digest - 28 February to 06 March 2026 - Optimal Dose
AI創薬に集まる巨額資金：Earendil Labsの約1200億円調達が示す生成AIの事業実装と日本企業への示唆 – グローバルAIメディア
BioPharmaPulse
25.6亿美元！赛诺菲再次与华深智药达成合作协议医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Sanofi doubles down on China‘s Helixon in second AI bispecific deal ...
